-

Illumina to Webcast Upcoming Investor Conference

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

  • UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021
    Fireside Chat at 12:00 pm Pacific Time (3:00 pm Eastern Time)

The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.

Contacts

Investors:
Brian Blanchett
+1.858.291.6421
ir@illumina.com

Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com

Industry:

Illumina, Inc.

NASDAQ:ILMN
Release Versions
English
$Cashtags
$ILMN
Hashtags
#ILMN
#Illumina

Contacts

Investors:
Brian Blanchett
+1.858.291.6421
ir@illumina.com

Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com

More News From Illumina, Inc.

Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase

SAN DIEGO--(BUSINESS WIRE)--Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase....

Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results. Conference Call Details T...

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis

SAN DIEGO--(BUSINESS WIRE)--Illumina and BeSolveRD will study the clinical utility and health economic impact of WGS of patients with intellectual disabilities....
Back to Newsroom